Cengild Medical Bhd (CENGILD) is regarded as a specialised healthcare service provider in the diagnosing and treating gastrointestinal and liver diseases and obesity. Their partnership with more than 20 insurance providers in Malaysia provides a wide range of access for patients to facilitate cashless payments in the form of guarantee letters from the insurance companies and third-party administrators.

Despite the slower contribution from Ambu, growth from the medical segment will be anchored by new products coming onto stream in 2023. This include IHS nonelectric syringe infusion system that will see mass production coming onto stream in December 2022, Ambu’s Falcon–C (colonoscope) in 2QFY23 and Plass’ soldier first aid hemostatic product that is still awaiting for FDA approval.

Looking ahead into 2023. OSK aims to rollout approximately RM1.00bn worth of gross development value (GDV) new launches. This comprises a healthy mixture from their (i) existing 2 townships located at Sg. Petani, Kedah and Seremban, Negeri Sembilan as well as (ii) several high-rise residential projects across Klang Valley. After acquiring some 89-ac of land (50-ac at Sg. Petani and 39-ac at Seremban) for a total of RM41.0m year-to-date, OSK will also remain active in their land banking replenishment activities, with the focus on lands adjacent to their 2 townships.

The FBM KLCI rebounded after a 5-day selldown and amid broad-based buying interest emerged in tandem with the positive sentiment across regional markets. However, given the pullback last week on Wall Street, the local bourse may trade in a range bound mode this week ahead of a series of interest rate decisions from the US Fed, UK Bank of England, and European Central Bank. Nevertheless, investors will be looking forward to China’s further reopening and easing of Covid-19 restriction.

Ramssol Group Bhd (RAMSSOL) is regarded as a human capital management (HCM) solution and technology specialist provider with regional presence across 5 countries. Some their key customers include notable entities such as Capitaland Ltd, RHB Bank Bhd, National University of Singapore, Paramount Corporation Bhd, ThaiFoods Group PLC and Export Import Bank of Thailand.

The FBM KLCI was dragged down marginally by the selldown in Petronas-linked heavyweights; 5-day net foreign selling stood at year-to-date high of RM938.8m. The global stock markets are deploying a wait-and-see approach as investors are waiting for more details from the upcoming FOMC meeting, focusing on the US Fed’s interest rate decision next week. Nevertheless, we believe some bargainhunting activities to emerge on the domestic front following the Covid-19 easing measures in China.

The FBM KLCI extended its losing streak as investors continued to stay on the sidelines. While investors may cheer for China’s easing of Covid-19 restrictions, gains might be capped as worries over the US Federal Reserve long rate-hike cycle could dampen the economic growth going forward. On the local front, we believe focus will be on the re tabling of Budget 2023 and traders will be watching the developments on the tackling of high living costs by the government.

EP Manufacturing Bhd (EPMB) started off since 1982 and commenced the manufacturing of moulds in 1991. Today, EPMB manufactures a wide range of products such as engineering plastic components, metal stamping parts and/or modular assemblies for both domestic and international automotive OEMs, including Proton, Perodua, Toyota, TRW, Honda and Suzuki.